Consumers will soon pay considerably less for Boniva, the once-a-month drug that is primarily used to treat osteoporosis in post-menopausal women. The FDA has approved a generic version of the drug, ...

Osteoporosis drugs are big sellers, bringing in some $2 billion in 2008 alone. Now one of the newest of those drugs, ibandronate, also known as Boniva, has scored major (and no doubt expensive) ...

A federal judge issued a ruling Thursday allowing GlaxoSmithKline and Roche to continue marketing the osteoporosis drug Boniva, shooting down an injunction filed by market rivals to halt the drug’s ...

Boniva (ibandronate) is a brand-name oral tablet that’s prescribed to help prevent and treat osteoporosis. As with other drugs, Boniva can cause side effects, such as jaw or teeth problems. In rare ...

The Food and Drug Administration said Wednesday it's conducting a safety review of certain bone-building drugs like Fosamax and Boniva to see if they increase the risk of femur fractures.

And Finally... AstraZeneca's ($AZN) exiting CEO David Brennan may be a $65 million example of the Peter Principle, says the Philly.com health blog. Post ...

PARSIPPANY, N.J. — The Food and Drug Administration has approved Watson's generic version of a drug used to prevent and treat osteoporosis in post-menopausal women, the company said. Watson announced ...

(Reuters) - The first generic versions of Roche's bone-strengthening drug Boniva have been approved by the U.S. Food and Drug Administration. Boniva, known generically as ibandronate, is taken once a ...